| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.75 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.42 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.39 | 0.02 |